Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Assuming just 10% of eligible beneficiaries use Wegovy in a given year, and assuming a 50% rebate on the list price, Medicare would incur nearly $3 billion in additional net Part D spending for one year for this one drug alone.KFF also finds that beneficiaries who take Wegovy could face monthly out-of-pocket costs of $325 to $430 if they have to pay a percentage of the drugs $1,300 list price for a months supply
It works by mimicking GLP-1, a natural hormone that regulates appetite, slows digestion, and stabilizes blood sugar
Ensuring adequate protein intake, maintaining nutritional supplementation, and avoiding excessive caloric restriction during transitions can help minimize this risk
Available from: Lkemedelsverket (2023) Frskriv inte diabeteslkemedel fr viktnedgng
It has been studied for its potential benefits in neurodegenerative diseases like Alzheimer's
